Hims & Hers Health valuation
$29.41Change from previous close: −0.20%Absolute change: −$0.06
Valuation
The average price target of 13 analysts is $31.15.
Data as of October 7, 2026
Valuation multiples
- Market cap
- $6.88B
- Enterprise value
- $7.58B
- Forward P/E
- 40.0
- PEG
- 2.71
- Price/book
- 21.2
- Price/sales
- 2.67
- EV/EBITDA
- -744.9
- EV/revenue
- 2.94
Profitability and growth
- Gross margin
- 69.5%
- Operating margin
- -12.8%
- Net margin
- -5.5%
- ROE
- -32.0%
- ROA
- -2.2%
- ROIC
- -10.5%
- Revenue growth (year over year)
- 38.2%
Financial health
- Total cash
- $841.05M
- Total debt
- $1.55B
- Debt/equity
- 4.77
- Current ratio
- 0.93
- Quick ratio
- 0.82
- Altman Z-Score
- 1.98
- Piotroski F-Score
- 2.00
Dividends
- Dividend yield
- 0.0%
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- $31.15
- Median price target
- $31.00
- High price target
- $42.00
- Low price target
- $23.00
- Analysts with a price target
- 13
- Consensus
- Hold
- Forward EPS
- $0.74
- EPS estimate, current year
- -$0.56
Shares and trading
- Beta
- 2.43
- Average volume
- 12.12M
- Shares outstanding
- 224.94M
- Float
- 213.75M
- Institutional ownership
- 71.1%
- Insider ownership
- 4.9%
- Short interest (% of float)
- 27.3%
- Short ratio (days)
- 4.92